These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 37228239)
1. UnWNTing the Heart: Targeting WNT Signaling in Pulmonary Arterial Hypertension. Goncharova EA; Kudryashova TV; de Jesus Perez VA; Rafikova O Circ Res; 2023 May; 132(11):1486-1488. PubMed ID: 37228239 [No Abstract] [Full Text] [Related]
2. A review of BMP and Wnt signaling pathway in the pathogenesis of pulmonary arterial hypertension. Xin Z; Wang J; Li S; Sun C; Jiang W; Xin Q; Wang J; Qi T; Li K; Zhang Z; Luan Y Clin Exp Hypertens; 2022 Feb; 44(2):175-180. PubMed ID: 34821188 [TBL] [Abstract][Full Text] [Related]
3. Too hot? Too cold? Wnt signalling in pulmonary arterial hypertension: can we treat it "just right"? Goncharova EA; Kudryashova TV; Pullamsetti SS Eur Respir J; 2023 Jun; 61(6):. PubMed ID: 37290809 [No Abstract] [Full Text] [Related]
4. Loss of Endothelium-Derived Wnt5a Is Associated With Reduced Pericyte Recruitment and Small Vessel Loss in Pulmonary Arterial Hypertension. Yuan K; Shamskhou EA; Orcholski ME; Nathan A; Reddy S; Honda H; Mani V; Zeng Y; Ozen MO; Wang L; Demirci U; Tian W; Nicolls MR; de Jesus Perez VA Circulation; 2019 Apr; 139(14):1710-1724. PubMed ID: 30586764 [TBL] [Abstract][Full Text] [Related]
5. The Pathobiology of Pulmonary Arterial Hypertension. Rajagopal S; Yu YA Cardiol Clin; 2022 Feb; 40(1):1-12. PubMed ID: 34809910 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of Klotho potentially inhibits pulmonary vascular remodeling by blocking the activation of the Wnt signaling pathway in rats with PM2.5-induced pulmonary arterial hypertension. Cong LH; Du SY; Wu YN; Liu Y; Li T; Wang H; Li G; Duan J J Cell Biochem; 2018 Jul; 119(7):5581-5597. PubMed ID: 29380911 [TBL] [Abstract][Full Text] [Related]
7. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease. Zhou JJ; Li H; Qian YL; Quan RL; Chen XX; Li L; Li Y; Wang PH; Meng XM; Jing XL; He JG J Mol Cell Cardiol; 2020 Dec; 149():41-53. PubMed ID: 32950539 [TBL] [Abstract][Full Text] [Related]
8. Metabolics of PH - an update. Hughes AL; Hemnes AR Curr Opin Pulm Med; 2021 Sep; 27(5):329-334. PubMed ID: 34127621 [TBL] [Abstract][Full Text] [Related]
9. Targeting the Wnt signaling pathways in pulmonary arterial hypertension. de Jesus Perez V; Yuan K; Alastalo TP; Spiekerkoetter E; Rabinovitch M Drug Discov Today; 2014 Aug; 19(8):1270-6. PubMed ID: 24955837 [TBL] [Abstract][Full Text] [Related]
11. New progress in diagnosis and treatment of pulmonary arterial hypertension. Zhang ZQ; Zhu SK; Wang M; Wang XA; Tong XH; Wan JQ; Ding JW J Cardiothorac Surg; 2022 Aug; 17(1):216. PubMed ID: 36038916 [TBL] [Abstract][Full Text] [Related]
12. ECMO in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension as a bridge to therapy. Cruz-Utrilla A; García-Martín EP; Domínguez Pérez L; Ruiz Curiel A; Quezada A; Durante López A; Vicent L; Martín Asenjo R; Hinojosa W; Eixerés A; Forcén Acebal L; Galindo M; Arribas Ynsaurriaga F; Escribano-Subias P; Bueno H Kardiol Pol; 2023; 81(5):500-504. PubMed ID: 36871299 [No Abstract] [Full Text] [Related]
13. Request to "Update" the 2019 Update of Guidelines for Management of Pulmonary Arterial Hypertension. Durrani J; Toor A Chest; 2019 Jul; 156(1):187. PubMed ID: 31279369 [No Abstract] [Full Text] [Related]
15. Reverse remodeling of small pulmonary arteries and right ventricle in pulmonary arterial hypertension. Tahara N; Sugiyama Y; Tahara A; Bekki M; Maeda-Ogata S; Honda A; Igata S; Abe T; Fukumoto Y J Nucl Cardiol; 2022 Dec; 29(6):3615-3618. PubMed ID: 34244964 [No Abstract] [Full Text] [Related]
16. Percutaneous Treatment of Left Main Coronary Artery Compression in a Pulmonary Artery Hypertension Patient Associated with Atrial Septal Defect. Deniz MF; Sinan ÜY; Yıldız A; Ökçün EBÖ; Küçükoğlu MS Turk Kardiyol Dern Ars; 2023 Apr; 51(3):221-225. PubMed ID: 36999326 [TBL] [Abstract][Full Text] [Related]
17. Targeting Wnt-ß-Catenin-FOSL Signaling Ameliorates Right Ventricular Remodeling. Nayakanti SR; Friedrich A; Sarode P; Jafari L; Maroli G; Boehm M; Bourgeois A; Grobs Y; Khassafi F; Kuenne C; Guenther S; Dabral S; Wilhelm J; Weiss A; Wietelmann A; Kojonazarov B; Janssen W; Looso M; de Man F; Provencher S; Tello K; Seeger W; Bonnet S; Savai R; Schermuly RT; Pullamsetti SS Circ Res; 2023 May; 132(11):1468-1485. PubMed ID: 37042252 [TBL] [Abstract][Full Text] [Related]
18. Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension. Satoh K; Kikuchi N; Kurosawa R; Shimokawa H Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1504-1506. PubMed ID: 31339778 [No Abstract] [Full Text] [Related]
19. The importance of right ventricular remodelling in pulmonary arterial hypertension. D'Alto M; Badagliacca R Heart; 2022 Aug; 108(17):1338-1339. PubMed ID: 35606110 [No Abstract] [Full Text] [Related]
20. Still puzzling about a clear definition of pulmonary arterial hypertension in newborns. Calcaterra G; Fanos V; Bassareo PP Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30923176 [No Abstract] [Full Text] [Related] [Next] [New Search]